To highlight the excellence and expertise of French academic research teams.
Exchange around innovative projects.
Establishment of partnerships building, encourage international investments and support the competitiveness of France at a global level.
This one-day event comprises two phases
Presentation of cutting-edge findings by industrials and academics researchers (Round-tables discussions, academics pitches, presentation of public-private partnerships)
Morning
Presentation of cutting-edge findings by industrials and academics researchers (Round-tables discussions, academics pitches, presentation of public-private partnerships)
One-to-one meetings between the researchers of the academic or industrial field
Afternoon
One-to-one meetings between the researchers of the academic or industrial field
The main themes targeted by the International R&D Dating during the last years have been:
2009 : Neurosciences
2010 : Cardiovascular and metabolic diseases
2011 : Infectious diseases
2012 : Cancer
2013 : Inflamations
2015 : Rare diseases and personalized medicine
2016 : Neurosciences and psychiatry
2018 : Immuno-Oncology
February 6th, 2018 in Palais d'léna
This year, the 8th International R&D Dating is organized under the theme «Immuno-oncology». It will take place in February 6th, 2018 in the Palais d’Iéna. Organized in partnership with AVIESAN’s cancer multi-agency thematic institute (ITMO Cancer), the French International R&D Dating will be attended by representatives from about 19 biomedical research firms* and about 40 academic researchers.
*Abbvie , AstraZeneca, BMS, Boehringer Ingelheim, GSK, Institut Mérieux, Institut Roche, Ipsen, Janssen, LFB, Merck, MSD, Novartis, Pfizer, Pierre Fabre, Roche Diagnostics, Sanofi, Servier, Takeda.
